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The interdisciplinary field of tissue engineering has changed over the last several years. The once expanding field has decreased with a more realistic approach regarding specific tissue types. Particularly with nerve tissue, initial enthusiasm with promising results obtained in vitro soon diminished with the harsh reality that cells and growth factors did not behave as expected in the clinical situation. Furthermore, the ability to bridge small nerve gaps in a rat or mouse model could not be translated directly to the clinical setting where larger (2 to 3 cm) gaps are clinically common. Last, the diversity of the nervous system demands differing approaches in different locations. For example, the central nervous system's support cells (astrocytes) seem to be more inhibitory to axonal proliferation as compared with the peripheral system's Schwann cells [4] . Sensory nerves seem to respond better to regeneration than motor neurons [5] . Consequently, more distal injuries seem to have better long-term results because division of the motor and sensory branches is more delineated with greater distance from the spinal cord.
To understand the complicated interaction of nerve components for tissue engineering, one must first understand the molecular interactions in nerve injury or repair. Although significant progress has been made in this field, full elucidation of the complex interactions of nerve repair falls short. We are in an infancy of an era of tissue engineering.
In the United States, more that 50,000 surgical procedures are performed each year for peripheral nerve repair and the number of injuries is estimated to be even greater [6, 7] . Economically, this translates into a significant amount of lost worker days due to the extent of work-associated injuries to the upper extremity. Tissue engineering in peripheral nerve repair will clearly have increased clinical applicability, but the question remains whether we can develop and use a functional tissue engineered nerve construct. This review will address current developments in peripheral nerve tissue engineering and the impact these will have in the future. To understand current approaches to nerve engineered constructs, several critical components should be considered: scaffolds for mechanical support, support cells, growth factors, and some unidentified material that we term ''extra-cellular matrix.''
Scaffolds
Original attempts at nerve repair date back to 1608, but it was not until the nineteenth century that physicians began to focus considerable effort on nerve restoration [8] . Unfortunately, most early surgical reconstructive techniques for the repair of peripheral nerve defects resulted in poor functional recovery. Alternative materials, including fat sheaths, gauze, bone, and metal tubes were used in an attempt to repair damaged nerves [9] . In the 1960's, Millesi introduced the concept of microsurgery, in which individual nerve fascicles in each nerve stump could be precisely aligned and tension minimized as a means to dramatically improve the success of nerve regeneration [10] [11] [12] There are several key properties that all guidance channels should possess: (1) they must be readily formed into a conduit having a desired diameter and wall thickness, (2) they should be simple to implant using microsurgical techniques, (3) they must be sterilizable, and (4) they should be biodegradable [13] . Permanent materials are less desireable because they may pose a more severe risk of infection, tend to provoke connective tissue responses, and can compress nerves or become dislodged. Synthetic and natural materials have been used for guidance channels. Williams, et al. demonstrated that when silicone tubes are used, within hours the tubes fill with nerve cables and blood vessels. During the second week, fibroblasts, Schwann cells, macrophages, and endothelial cells permeate the fibrin matrix. Axons sprouting from the proximal nerve stump elongate along the matrix [14, 15] (Fig. 1) .
Considerable focus has been placed on the use of natural materials for nerve scaffolds. Various autologous tissues have been demonstrated to increase regeneration competence in rats including epineurial sheaths, tendon, vein [16] and basal laminae extracted from decellularized muscle [4] . These autologous tissues have also been impregnated with growth factors or coated with collagens for further stimulation of axonal outgrowth and Schwann cell migration [16] Raimondo et al. recently demonstrated a vein filled with skeletal muscle as a suitable means of sustaining Schwann cell migration and proliferation [17] . The advantage of biocompatibility decreases the potential toxic effect of using inert or synthetic material. The hurdle that remains is the undesirable immune response depending on the patient or the source of the material [13, 18] . Allografts and xenografts have not been effective clinically because of issues with host response. Acellular grafts, although non-immunogenic, tend to result in a significant degree of inflammation when implanted, mainly because the decellularization fails to completely extract cellular remnants or leaves damaged extracellular matrices. However, due to the current literature there have been a number of studies which have demonstrated the reconstruction of relatively large nerve gaps with acellular nerve grafts repopulated with autogenous "support cells" or enhanced with growth factors [4] . In addition, these allografts have been modified so they are less immunogenic and have also been repopulated with autogenous schwann cells to allow reconstruction of large gaps. This is indeed a tissue engineering approach for developing alternative peripheral nerve constructs. Recent approaches with chemical detergents have proven more effective in preserving structural integrity [19] . The potential use of cadaveric products through specialized processing may eliminate the cells responsible for this immunologic reaction, leaving the backbone structure for axonal growth. Further, recent work has demonstrated that low-dose immunosuppression with FK 506 has yielded improved regeneration with the use of allografts [20] [21] .
Several biodegradable synthetic materials have been demonstrated to support nerve regeneration. Polyesters such as polylactic acid, polyglycolic acid, and poly(lactic-co-glycolic acid) (PLGA) were early choices for investigation because of their availability and FDA approval [13] . Although a variety of additional materials have been developed, the approval of PLGA for clinical use has encouraged its use over other materials. Physical properties, such as conduit dimensions, wall porosity, surface texture, and inherent electrical properties, also dramatically influence the effects of nerve regeneration [13] . These alterations in physical properties directly effect the diffusion of nutrient materials, allow the acceleration of axonal growth for certain characteristics such as smooth surfaces, and may inhibit detrimental cells such as fibroblasts, which may cause further scar formation [5] .
The exact nature of the ideal conduit is unknown. A combination of synthetic and natural materials may be the ideal solution. The ability of axons to traverse an autograft through preset channels created by Schwann cell alignment has not been duplicated with the materials or designs currently in use. The use of a round tube may not be the most ideal construct for larger nerve gaps. New innovations such as electrical poling have also been applied to bioengineered conduits and have increased the ability of injured nerves to reach their target organs through enhanced axonal regeneration and improved conduction rates [22] . As our ability to design and modify scaffold material to appropriate sizes and dimensions improves, the correct combination will be found.
Support cells
The inclusion of neuronal support cells is critical for axonal proliferation. Although the exact underlying mechanisms regulating dynamic axon/Schwann cell apposition are unknown, experiments support the concept that Schwann cells offer a highly preferred substrate for axon migration and release of bioactive factors that further enhance nerve migration [20] . In the normal nerve, Schwann cells seem to be quiescent; however, upon nerve injury, Schwann cells in the distal nerve undergo extensive change concomitant with axonal degeneration. Within hours, Schwann cells begin to express MAC-2, a galactose-specific lectin, which targets the galactolipid-rich myelin in nonimmune opsonin-independent lectinphagocytosis and mediates the bulk of phagocytosis within the first few hours of injury. This phagocytosis is also supported by the migration of macrophages [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . Thus, Schwann cells play an important role in peripheral nerve regeneration probably through several mechanisms. These include the release of growth factors and perhaps a mechanical role by bridging the gap between axonal growth cone migration and the basement membrane. Despite the role that Schwann cells play, studies that have demonstrated improved axonal growth by placing Schwann cells within a scaffold have not solved all of the problems of axonal regeneration [34] [35] [36] [37] [38] [39] . Questions regarding immunogenicity remain. How long can these Schwann cells survive? Can these cells be pre-placed within a conduit and remain viable for transportation and implantation? Further, the use of autogenous Schwann cells would still require the harvest of peripheral sensory nerves for culture and expansion before implantation.
Alternative sources of cells must be explored. Data from our laboratory has demonstrated the ability of fibroblasts to act like Schwann cells, releasing nerve growth factors (NGF) for axonal proliferation [40] . The use of genetically engineered dermal fibroblast cells allows ease of harvest (through skin biopsy), ease of expansion and growth, and more resilience for implantation. However, the concerns of excessive scar formation have limited our initial enthusiasm for these cells. Alternative cells (HEK-293) have recently been used and may offer similar efficacy without the elevated risk of scar formation [41] [42] [43] . Apart from inducing a limited immunologic response, this cell line is human and embryonic, making it a promising delivery system for inducible expression of growth factors [41] [42] [43] .
With the growing applicability of stem cells in all avenues of medicine, increased opportunities become available to allow the use of a variety of cell lines for nerve differentiation such as embryonic stem cells, bone marrow-derived stem cells, somatic pluripotent stem cells, adipose-derived stem cells, mesenchymal stem cells, and progenitor cells [44] [45] . The advantage of using these cells lines is that the potential differentiation may be stimulated by the advancing axons. Furthermore, it is postulated that Schwann cells are the primary support cells for axonal migration peripherally. Additional cells, though, may be responsible for this axonal growth. Pluripotent stem cells may allow multiple differentiation paths, creating an environment that is ripe for the support of axon regeneration. The majority of this work to date has been focused in the central nervous system, although there have been recent developments peripherally. Murakami et al. transplanted neuronal progenitor cells derived from the fetal hippocampus in the rat model and demonstrated their differentiation into Schwann cells that helped promote axonal regeneration through a nerve defect [46] . Neural stem cells have also been effective at restoring motor function in the setting of chronically denervated peripheral nerves [47] . Neural stem cells have been identified in the adult central nervous system and have successfully been propagated in vitro, but the source of donor tissue and expansion difficulty of such cells could pose a significant barrier [48] . Olfactory ensheathing cells (OEC's) have been described as the progenitor cells of the peripheral nervous system [49] . They are a glial-cell type and continually regenerate to myelinate the olfactory nerves. OEC's have stimulated axonal regeneration in the spinal cord; their potential in the peripheral nervous system is still debatable [4, 49] . Hair follicle stem cells, which may be easier to access, have been transdifferentiated into Schwann cells and indicate promise in enhancing rate of restoration of nerve function [50] . Bone marrow stromal cells, or mesenchymal stem cells (MSC), have a similar advantage in their accessibility, and demonstrate comparable results in supporting peripheral nerve regeneration, mainly by exhibiting characteristics similar to Schwann cells [51] [52] [53] [54] . MSC's can be differentiated to glial-type cells via induction with various mitogens in vitro. Tohill and Torenghi have demonstrated that these cells may confer some beneficial effect on Schwann cell growth indicating both stimulatory and supportive roles [49] . Given the apparent plasticity of such stem cells and their presence in adult tissues, it is certain that stem cells will be integral components in neural tissue engineering.
Growth factors
Soluble neurotropic and neurotrophic factors can be incorporated directly into nerve guidance conduits. Some of these factors include NGF, brain-derived neurotrophic factor (BDNF), insulin-like growth factor (IGF-1, IGF-2), platelet-derived growth factors, fibroblast growth factor, and ciliary neurotrophic factor. Although a variety of family compounds (e.g., neurotrophins, cytokines, and insulin derivatives) stimulate peripheral nerve migration directly or indirectly, NGF seems to have the greatest effect [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] . There is increasing evidence that many neurotrophic molecules (NGF, BDNF, NT-3, NT-4/5) act directly to promote survival and indirectly on regenerating axons via non-neuronal cells. NGF has been demonstrated to prevent the death of axotomized sensory neurons completely after exogenous administration [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] .
Growth factors can be delivered through a variety of mechanisms. Traditionally, growth factors were delivered exogenously through the application of tubes or injections. This delivery system allows a one-time ''spike'' that occurs after the application. Further, the delivery of growth factors in the desired concentration at the axonal/Schwann cell interface (location specific) cannot be regulated. Alternative methods for delivery have been explored, including the use of microsphere technology [4] . The problem with microsphere delivery of growth factors is that degradation can be variable. Degradation begins immediately upon delivery, although recent work demonstrates that growth factor delivery duration can be sustained for an extended period of time [70] . Growth factor levels may require alternative delivery times and sequences. The same holds true for the application and incorporation of growth factors within synthetic scaffolds. Thus, protocols for the use of growth factors must address the sequence, timing, dosage, delivery vector, and duration of therapy [71] [72] [73] . In an attempt to incorporate these issues in growth factor delivery, focus has turned to plasmid or viral vectors as modes of controlled gene expression of growth factors. Retrovirus, adenoassociated virus, adenovirus, and herpes virus have all been utilized as vehicles for gene therapy, with the latter two being more common in neural application. Transfection of delivery cells with Muristerone A, or similar derivatives, or tetracycline-responsive promoters has also proven to be a successful means of molecular control [4] . Our laboratory has successfully regulated NGF secretion in vitro and in vivo, allowing dosing, timing, and continued release through the transfection of HEK-293 cells [41] [42] [43] . We believe that this application offers a more attractive delivery mechanism than what has previously been used.
Extracellular matrix
The additional factors that must be incorporated into tissue engineered nerve constructs are unknown. We have tentatively labeled this as ''extracellular matrix.'' If support cells, scaffolds, and growth factors were all that was needed, we should have been able to produce a tissue engineered construct. There seems, however, to be some additional material or a combination of materials that is missing. Insoluble extracellular matrix molecules, including laminin, fibronectin, and some forms of collagen, have been demonstrated to promote axonal extension. They have been demonstrated to improve axonal regeneration when incorporated into the lumen of nerve guidance channels [74] [75] [76] [77] . Chitosan, a polysaccharide derivative of chitin, possesses antitumor and antibacterial properties and has been shown to promote migration and proliferation of Schwann cells, thereby gaining increased interest to promote nerve regeneration [78] . Combinations of natural materials have also gained approval. For example, a chitosan/peptide blend conduit has been found to improve adhesion and differentiation of PC12 cells when compared to chitosan or composite material alone [7] . Poly-3-hydroxybuturate, a natural polymer used as a bacterial storage product, has also demonstrated utility as an alternative for a conduit in bridging nerve gaps in rabbits [79] . The incorporation of extracellular matrix materials alone, however, is not enough. Future directions may allow us to determine the ''missing link.''
Future directions
Primary neurorrhaphy and use of nerve autografts remain the gold standards for nerve gap repair. Significant advances have been made in devising alternatives to these options, including use of bioengineered conduits, manipulation of growth factor expression through genetic engineering, and induction of stem cell differentiation. With respect to incorporation of many of these applications clinically, we find ourselves at a stage of infancy with many barriers remaining to be overcome. It is evident that different cell types often require unique culture environments, making it difficult to design a multilayer tissue engineered construct. Ahead lies the challenge to create a scaffold capable of supporting a variety of cell types through histioconductive processes. There remains much to learn regarding the use of growth factors. The appropriate dosing or the complex cascade and coordinated sequences of their elaborations are not completely understood. Many growth factors have pleiotropic effects on cells. Defining precisely the appropriate expression sequence, dosing, and duration for growth factors is critical. Genetic engineering may hold the key to future development of tissue engineered nerve constructs. With the ability to identify and perhaps delete specific genetic sequences, we might be able to identify, modify and/ or manipulate genes critical to neuronal development. Embryonic stem cells and pleuripotent cells will likely have a strong impact on advances toward finding a suitable alternative to autologous nerve grafts. Perhaps the answer to the ideal bioengineered nerve graft will come as a mélange of all these factors. In any instance, similar to other developments in different fields of Tissue Engineering [80] [81] [82] [83] [84] , we are headed for a future filled with exciting new developments.
